Number of the records: 1
Human multidrug-resistant (MRP, P 190) myeloid leukemia HL-60/ADR cells in vitro: resistance to the mevalonate pathway inhibitor lovastatin
SYS r002889 LBL ^^^^^naa^^22^^^^^^^^450^ 005 20201118143927.5 100 $a 20001005a1997 m y0sloc0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a Human multidrug-resistant (MRP, P 190) myeloid leukemia HL-60/ADR cells in vitro: resistance to the mevalonate pathway inhibitor lovastatin $f Ľ. Hunáková ... [et al.] 215 $c Obr., tab. 320 $a Res. angl. 320 $a Bibliogr. odkazy 463 -1
$1 001 sllk_un_cat*sg000148_1997_097_006 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Roč. 44, č. 6 (1997), s. 366-369 541 1-
$a Ľudské viacnásobne rezistentné (MRP, P 190) myeloidné leukemické bunky HL-60/ADR in vitro: rezistencia k mevalonátovej ceste inhibítora lovastatínu 606 0-
$a lovastatín $x aplikácia a dávkovanie $x farmakokinetika $2 mesh $3 sllk_un_auth*d008148 606 0-
$3 sllk_un_auth*d004351 $a rezistencia lieková $2 mesh 606 0-
$a bunky kultivované $2 mesh $3 sllk_un_auth*d002478 606 0-
$a leukémia $x diagnostika $2 mesh $3 sllk_un_auth*d007938 606 0-
$a glykoproteíny $x metabolizmus $2 mesh $3 sllk_un_auth*d006023 606 0-
$a delenie bunky $x genetika $x imunológia $2 mesh $3 sllk_un_auth*d002455 610 2-
$a kultúry bunkové 610 2-
$a línie bunkové transformované 675 $a 576.385.5:615.277.3 $v 1. stred. $z slo 701 -1
$3 sllk_un_auth*p0055227 $a Hunáková $b Ľubica $4 070 702 -1
$3 sllk_un_auth*p0050699 $a Sedlák $b Ján $4 070 702 -1
$a Šuliková $b M. $3 sllk_un_auth*p0050697 $4 070 702 -1
$3 sllk_un_auth*p0050698 $a Chovancová $b Jana $4 070 702 -1
$a Duraj $b J. $3 sllk_un_auth*p0050694 $4 070 702 -1
$3 sllk_un_auth*0012341 $a Chorváth $b Branko $4 070 801 -0
$a SK $b BA006 $c 20001005 $g AACR2
Number of the records: 1